HK1144252A1 - Methods for drug screening using non-invasive in vivo imaging - Google Patents

Methods for drug screening using non-invasive in vivo imaging

Info

Publication number
HK1144252A1
HK1144252A1 HK10110682.0A HK10110682A HK1144252A1 HK 1144252 A1 HK1144252 A1 HK 1144252A1 HK 10110682 A HK10110682 A HK 10110682A HK 1144252 A1 HK1144252 A1 HK 1144252A1
Authority
HK
Hong Kong
Prior art keywords
invasive
methods
drug screening
vivo imaging
vivo
Prior art date
Application number
HK10110682.0A
Other languages
English (en)
Inventor
Per Olof Berggren
Alejandro Caicedo
Original Assignee
Biocrine Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biocrine Ab filed Critical Biocrine Ab
Publication of HK1144252A1 publication Critical patent/HK1144252A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/37—Digestive system
    • A61K35/39—Pancreas; Islets of Langerhans
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • A01K67/0271—Chimeric vertebrates, e.g. comprising exogenous cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0676—Pancreatic cells
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/10—Mammal
    • A01K2227/105—Murine
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/03—Animal model, e.g. for test or diseases
    • A01K2267/0306—Animal model for genetic diseases
    • A01K2267/0325—Animal model for autoimmune diseases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
    • A61K49/0008—Screening agents using (non-human) animal models or transgenic animal models or chimeric hosts, e.g. Alzheimer disease animal model, transgenic model for heart failure
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/008—Vector systems having a special element relevant for transcription cell type or tissue specific enhancer/promoter combination

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Cell Biology (AREA)
  • Zoology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Environmental Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Virology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Immunology (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Animal Husbandry (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Hematology (AREA)
  • Toxicology (AREA)
  • Pathology (AREA)
  • Urology & Nephrology (AREA)
  • Rheumatology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
HK10110682.0A 2007-08-31 2010-11-17 Methods for drug screening using non-invasive in vivo imaging HK1144252A1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US96943707P 2007-08-31 2007-08-31
US98903807P 2007-11-19 2007-11-19
US4248208P 2008-04-04 2008-04-04
PCT/EP2008/007130 WO2009027106A2 (en) 2007-08-31 2008-09-01 Non-invasive in vivo imaging and methods for treating type i diabetes

Publications (1)

Publication Number Publication Date
HK1144252A1 true HK1144252A1 (en) 2011-02-11

Family

ID=40025468

Family Applications (1)

Application Number Title Priority Date Filing Date
HK10110682.0A HK1144252A1 (en) 2007-08-31 2010-11-17 Methods for drug screening using non-invasive in vivo imaging

Country Status (8)

Country Link
US (5) US20090060843A1 (ja)
EP (2) EP2441462B1 (ja)
JP (4) JP5883221B2 (ja)
DK (2) DK2441462T3 (ja)
ES (2) ES2732561T3 (ja)
HK (1) HK1144252A1 (ja)
PL (2) PL2194993T3 (ja)
WO (1) WO2009027106A2 (ja)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090060843A1 (en) * 2007-08-31 2009-03-05 Biocrine Ab Non-Invasive In Vivo Imaging and Methods for Treating Type I Diabetes
CN102575282B (zh) * 2009-09-18 2016-01-20 卡钳生命科学公司 生物发光体内评价的组合物和方法
WO2012051118A1 (en) * 2010-10-12 2012-04-19 University Of Miami Islet storing intraocular implant, method of using the same and kit including the same
CN103517723B (zh) 2011-05-13 2016-08-17 碧奥克里内股份公司 用于机动化注射和抽吸的系统和方法
US8557513B2 (en) 2011-06-27 2013-10-15 Biocrine Ab Methods for treating and/or limiting development of diabetes
US9462973B2 (en) 2012-07-27 2016-10-11 Biocrine Ab Methods for monitoring physiological status of a body organ
JP6161845B1 (ja) * 2016-11-14 2017-07-12 英次 湊 まつ毛増毛用器具、まつ毛の増毛方法、まゆ毛増毛用器具、及びまゆ毛の増毛方法
MX2021000621A (es) 2018-07-19 2021-04-13 Biocrine Ab Metodos y reactivos para tratar la diabetes.
WO2021155025A1 (en) * 2020-01-28 2021-08-05 The Board Of Trustees Of The Leland Stanford Junior University Preventing or treating pancreatic dysfunction or diabetes by upregulating human cathelicidin

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU1369039A1 (ru) * 1982-07-16 1988-09-07 Институт биологической физики АН СССР Способ моделировани компенсации сахарного диабета
US5650435A (en) * 1991-04-01 1997-07-22 Madara; James L. Modulation of inflammation related to columnar epithelia
US7255851B2 (en) * 1994-07-01 2007-08-14 The Board Of Trustees Of The Leland Stanford Junior University Non-invasive localization of a light-emitting conjugate in a mammal
US5650135A (en) * 1994-07-01 1997-07-22 The Board Of Trustees Of The Leland Stanford Junior University Non-invasive localization of a light-emitting conjugate in a mammal
DE19703734A1 (de) * 1997-01-31 1998-08-06 Univ Magdeburg Tech Anordnung und Verfahren zur nicht-invasiven Bestimmung und/oder Erzeugung funktioneller und/oder morphologischer Eigenschaften von Zellen des Auges im lebenden Organismus
KR19990014353A (ko) * 1998-10-17 1999-02-25 윤태욱 췌도의 대량 배양증식방법
AU2001249297B2 (en) * 2000-03-17 2006-11-23 Anticancer, Inc. Whole-body optical imaging of gene expression and uses thereof
US20050180959A1 (en) * 2002-02-06 2005-08-18 Karsten Eulenberg Kinases involved in the regulation of energy homeostasis
WO2004006838A2 (en) * 2002-07-15 2004-01-22 Sugen, Inc. Novel kinases
CN101282652B (zh) * 2005-06-02 2013-09-11 亚利桑那董事会（代表亚利桑那大学） 预血管化的装置及相关方法
US20090060843A1 (en) * 2007-08-31 2009-03-05 Biocrine Ab Non-Invasive In Vivo Imaging and Methods for Treating Type I Diabetes

Also Published As

Publication number Publication date
US20190070316A1 (en) 2019-03-07
JP2010536908A (ja) 2010-12-02
PL2194993T3 (pl) 2014-04-30
ES2447069T3 (es) 2014-03-11
JP2011256202A (ja) 2011-12-22
JP5883221B2 (ja) 2016-03-09
US20090060843A1 (en) 2009-03-05
WO2009027106A3 (en) 2009-07-23
EP2441462B1 (en) 2019-05-08
US9463205B2 (en) 2016-10-11
JP2014167023A (ja) 2014-09-11
US20170000907A1 (en) 2017-01-05
ES2732561T3 (es) 2019-11-25
US20200061121A1 (en) 2020-02-27
WO2009027106A2 (en) 2009-03-05
JP5882640B2 (ja) 2016-03-09
US20150064144A1 (en) 2015-03-05
US10207012B2 (en) 2019-02-19
JP2016074726A (ja) 2016-05-12
PL2441462T3 (pl) 2020-01-31
DK2194993T3 (da) 2014-01-27
EP2194993B1 (en) 2013-12-18
US10493108B2 (en) 2019-12-03
EP2194993A2 (en) 2010-06-16
EP2441462A1 (en) 2012-04-18
DK2441462T3 (da) 2019-06-24

Similar Documents

Publication Publication Date Title
EP2178442A4 (en) CATHETER FOR IMAGING IN-VIVO
HK1144252A1 (en) Methods for drug screening using non-invasive in vivo imaging
EP2155065A4 (en) PROCESS FOR THE IMAGE DISPLAY OF CELLS IN VIVO
GB0807611D0 (en) Dental imaging and apparatus thereof
EP1983926A4 (en) ENDOSCOPE WITH IMAGES CAPSULE
EP2344042A4 (en) METHODS OF ACQUIRING AND DISPLAYING IN ULTRASONOGRAPHY
EP2005806A4 (en) SETTING PATIENTS BY TOMOSYNTHESIS TECHNIQUES
EP2191318A4 (en) IMAGING APPARATUS
ZA201101700B (en) Daa-pyridine as peripheral benzodiazepine receptor ligand for diagnostic imaging and pharmaceutical treatment
EP2129295A4 (en) ULTRASONIC IMAGING METHOD AND DEVICE
EP2205159A4 (en) METHODS AND APPARATUS FOR ULTRASONIC IMAGING
GB0523506D0 (en) Novel in vivo imaging compounds
EP2075610A4 (en) IMAGE UNIT AND ENDOSCOPE THEREOF
EP2001362A4 (en) QUANTITATIVE OPTOACUSTIC TOMOGRAPHY WITH REINFORCED CONTRASTS
EP2231015A4 (en) COMPOSITE IMAGES FOR MEDICAL PROCEDURES
EP2187198A4 (en) BLOOD EXAMINATION APPARATUS
EP2340851A4 (en) DIAGNOSTIC METHOD AND THERAPEUTIC METHOD FOR CANCER
EP2136713A4 (en) METHODS AND DEVICE FOR ULTRASONIC IMAGING
EP2074816A4 (en) IMAGING APPARATUS
EP2069862A4 (en) IMAGING APPARATUS
EP2063784A4 (en) MEDICAL X-RAY DEVICE
EP2171478A4 (en) IN VIVO IMAGING METHOD FOR SULPHOTRANSFERASES
GB0701076D0 (en) Imaging apparatus
EP2257316A4 (en) CONTRAST AGENTS, METHODS FOR PREPARING CONTRAST AGENTS, AND IMAGING METHODS
EP2198040A4 (en) IN VIVO FIGURE OF MYELIN

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20200901